Fireside Chat:

Strategies for Measuring Success & Ensuring Compliance in Your 340B Program

Monday, March 31st, 1:00 - 1:30 pm EST

The 340B program serves as a critical resource for hospitals striving to provide comprehensive care to their patient populations. However, evolving operational requirements make it essential for covered entities to develop programs that are both scalable and adaptable.

Join us for an insightful fireside chat that will explore key strategies to build and sustain a successful 340B program while ensuring compliance in an ever-changing regulatory landscape.

 

What You’ll Learn ↓

Registration Form

Learning Objectives

Establish & Track Key Metrics

Learn best practices for accurately measuring 340B program performance.

Leverage Technology for Compliance

Discover how health systems utilize technology for real-time oversight, proactive auditing, and risk mitigation.

Optimize 340B Participation

Gain insights into maximizing your organization's impact and financial sustainability within the 340B program.

Stay Ahead of the Trends

Engage in discussions on the latest industry challenges and strategies for navigating regulatory complexities.

Speakers

Ted Slafsky
Ted Slafsky
CEO, 340B Report
Eric Manuel
Eric Manuel Balmir
VP of Clinical Ancillary Services & Chief Pharmacy Officer, Children’s National Hospital
Lauren Forni-1
Lauren Forni
Senior Director of Clinical Strategy, Bluesight
Ted Slafsky
Ted Slafsky
CEO, 340B Report
Eric Manuel
Eric Manuel Balmir
VP of Clinical Ancillary Services & Chief Pharmacy Officer, Children’s National Hospital
Lauren Forni-1
Lauren Forni
Senior Director of Clinical Strategy, Bluesight
Ted Slafsky
Ted Slafsky
CEO, 340B Report
Eric Manuel
Eric Manuel Balmir
VP of Clinical Ancillary Services & Chief Pharmacy Officer, Children’s National Hospital
Lauren Forni-1
Lauren Forni
Senior Director of Clinical Strategy, Bluesight
Ted Slafsky
Ted Slafsky
CEO, 340B Report
Eric Manuel
Eric Manuel Balmir
VP of Clinical Ancillary Services & Chief Pharmacy Officer, Children’s National Hospital
Lauren Forni-1
Lauren Forni
Senior Director of Clinical Strategy, Bluesight
Ted Slafsky
Ted Slafsky
CEO, 340B Report
Eric Manuel
Eric Manuel Balmir
VP of Clinical Ancillary Services & Chief Pharmacy Officer, Children’s National Hospital
Lauren Forni-1
Lauren Forni
Senior Director of Clinical Strategy, Bluesight